| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.63B | — | +84.7% |
| Cost of Revenue | $215.8M | — | +24.8% |
| Gross Profit | $1.42B | — | +99.3% |
| R&D Expense | $161.0M | — | +19.3% |
| SG&A Expense | $182.6M | — | +11.6% |
| Operating Income | $754.0M | — | +328.3% |
| Pre-tax Income | $888.6M | — | +297.9% |
| Income Tax | $12.2M | — | +117.9% |
| Net Income | $870.5M | — | +306.7% |
| EPS (Basic) | $0.36 | — | +300.0% |
| EPS (Diluted) | $0.34 | — | +325.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.29B | +61.0% | +130.7% |
| Short-term Investments | $5.73B | -0.3% | +29.2% |
| Accounts Receivable | $1.41B | +34.9% | +93.8% |
| Current Assets | $9.55B | +14.3% | +52.0% |
| Total Assets | $10.20B | +14.6% | +51.4% |
| Current Liabilities | $1.38B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $899.2M | — | +189.8% |
| Capital Expenditures | $7.4M | — | +19.7% |
| Investing Cash Flow | -$26.7M | — | +98.1% |
| Financing Cash Flow | $3.4M | — | +111.8% |
| Free Cash Flow | $891.8M | — | +193.3% |
| +42.9% |
| Total Liabilities | $1.64B | +16.3% | +34.9% |
| Stockholders' Equity | $8.45B | +14.4% | +55.8% |